Westminster, CA – June 7, 2021 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable clean- technologies and full-service environmental engineering company, will host its annual stockholder meeting on Tuesday June 15, 2021, at 10:00 am Pacific Time, via live webcast. In light of the continuing public health impact of the ongoing COVID-19 pandemic and to support the health and safety of the Company’s stockholders and attendees, the 2021 Annual Meeting will be held in a virtual-only meeting format.
Stockholders may register to attend the online Annual Meeting
at this link:
https://agm.issuerdirect.com/blgo
Members of the Board and Management team will discuss the Company’s
most recent annual and quarterly results and other general company matters, followed
by a question-and-answer session with stockholders and management.
It is important that
your shares be represented and voted at the Annual Meeting, whether or not you plan to attend online. Stockholders of record
as of April 19, 2021, may vote at the Annual Meeting. Please review the proxy statement
and vote in accordance with the instructions you received.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative
platform technologies to solve challenging environmental problems like PFAS contamination,
advanced water and wastewater treatment, industrial odor and VOC control, air quality
control, and infection control. With over 13 years of extensive R&D, BioLargo
holds a wide array of issued patents, maintains a robust pipeline of products, and
provides full-service environmental engineering. Our peer-reviewed scientific approach
allows us to invent or acquire novel technologies and develop them to maturity through
our operating subsidiaries. With a keen emphasis on collaborations with academic,
municipal, and commercial organizations and associations, BioLargo has proven itself
with over 80 awarded grants and numerous pilot projects. We monetize through direct
sales, recurring service contracts, licensing agreements, strategic joint venture
formation and/or the sale of the IP. Several of our technologies are commercially
available and are advancing as disrupters in their respective markets. See our website
at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
No comments:
Post a Comment